Analysis: Clamor for obesity pill may test FDA limits (Reuters)

Reuters – U.S. drug regulators may have a hard time stopping millions of overweight Americans from taking a new obesity drug that many are likely to view as a miracle pill for slimming waistlines, despite its safety risks.